Clinical Trials Logo

HIV Dementia clinical trials

View clinical trials related to HIV Dementia.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03081117 Terminated - HIV Dementia Clinical Trials

Intranasal Insulin for the Treatment of HAND

Start date: August 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

Infection with HIV (the virus that causes AIDS) can lead to problems with brain function, such as memory, concentration, judgment, and the speed or control of hands and legs. Neurologists have called this condition HIV-associated neurocognitive disorder (HAND). This research is being done to see if insulin taken through the nose as a spray (intranasal insulin) can help people with HIV who are having problems with memory and brain function, or HAND. Participants will be given either insulin or placebo. A placebo is an inactive substance that looks like the study drug, but does not contain study drug. For this research study, the placebo will be a clear, saline-based liquid spray that looks like the insulin spray but has no insulin. Participants will not be told whether they receive insulin or placebo during the study. All participants will take the intranasal spray twice a day, about 30 minutes after a meal. Participants will use a specialized intranasal drug administration device. The total daily dose of insulin is 40 IU split between 20 IU in the morning and 20 IU in the evening. Participants will take the intranasal spray for 24 weeks. The researchers will record symptoms and side effects during the study. Procedures include neurocognitive testing of memory and brain function, two optional lumbar punctures ("spinal taps"), two MRI brain scans, monthly blood draws, and clinical assessments.

NCT ID: NCT00459693 Terminated - Healthy Clinical Trials

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)

Start date: April 9, 2007
Phase: N/A
Study type: Interventional

The purpose of this protocol is to measure a receptor in the brain using positron emission tomography (PET) that is involved in inflammation.